$13.39 -0.34 (-2.48%)
11/6/2009 4:00 PM

BioMed Realty Trust, Inc. (BMR)

CAPS Rating: 3 out of 5

The Company is a real estate investment trust, or REIT, focused on acquiring, developing, owning, leasing and managing laboratory and office space for the life science industry.

Current Price $13.39 Mkt Cap $1.31B
Open $13.50 P/E Ratio 23.67
Prev. Close $13.73 Div. (Yield) 0.44 (3.20%)
Daily Range $13.23 - $13.69 Volume 1,094,313
52-Wk Range $5.88 - $15.31 Avg. Daily Vol. 1,278,000

BMR News and Commentary

Related News and Articles

Caps

How do you think BMR will perform vs the S&P 500?

Add Stock to Watchlist

All Members

65 Outperform
16 Underperform
 

All-Star Members

26 Outperform
5 Underperform
 

Wall Street

4 Outperform
1 Underperform
 

Top BMR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

puccini3005 (98.92)
Submitted April 03, 2009

BioMed Realty Trust is a relatively small REIT, specializing in the life science industry. An update - BMR now "owns or has interests in 69 properties, which include 112 buildings with approximately 10.4 million rentable square feet of… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

BMR VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about BMR.

Recs

1
Member Avatar puccini3005 (98.92) Submitted: 4/3/2009 2:48:07 AM : Outperform Start Price: $16.55 BMR Score: -31.45

BioMed Realty Trust is a relatively small REIT, specializing in the life science industry. An update - BMR now "owns or has interests in 69 properties, which include 112 buildings with approximately 10.4 million rentable square feet of laboratory and office space, including approximately 1.9 million square feet of development in progress...." (quote courtesy of the company home page).
I agree with the other bull pitchers that BMR is undervalued - great margins (profit and operating - 22% and 36% respectively), strong cash flow, and a low forward PE at 4.62.
The dividend is nice and fat too.
My timing was bad for when I bought my BMR shares, but even though the share price has gone down significantly, they have't yet decreased or suspended the dividend - they actually raised it a few times.

Recs

0
Member Avatar pslorenz (98.15) Submitted: 3/1/2009 4:41:56 PM : Outperform Start Price: $7.94 BMR Score: +18.37

I am jumping on this now as it looks way undervalued and it it positioned well in a still growing sector (given the current economy.) Govt spending may further add to the valueof this as thigs such as stem cell research get the funding green light again.

Recs

0
Member Avatar ErfanH (< 20) Submitted: 8/7/2007 12:56:31 PM : Outperform Start Price: $19.82 BMR Score: -9.08

Undervalued.

Leaderboard

Find the members with the highest scoring picks in BMR.

Score Leader

JakilaTheHun

JakilaTheHun (99.95) Score: +71.53

http://www.homestarrunner.com/buginmouth.html

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. JakilaTheHun 99.95 3/19/2009 Outperform 5Y $6.40 +109.17% +37.64% +71.53
PatternTrader 98.98 12/2/2008 Outperform NS $6.64 +101.57% +31.71% +69.86
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. alexvb 71.72 12/15/2008 Outperform 3Y $7.44 +79.94% +26.07% +53.86
mdhighdividend 97.06 3/17/2009 Outperform 3W $7.29 +83.66% +41.52% +42.14
dcdanb < 20 7/24/2008 Underperform 5Y $23.69 -43.49% -13.19% +30.29
JakilaTheHunREIT 57.61 6/23/2009 Outperform 5Y $9.33 +43.47% +20.30% +23.17
RFHGMJ 80.06 6/3/2008 7/12/2008 Underperform 1Y $22.83 -41.35% -20.25% +21.10
fredduck 59.55 7/13/2009 Outperform 3Y $9.48 +41.31% +21.89% +19.42
NeverShort 99.51 7/10/2009 Outperform 5Y $9.44 +41.90% +22.71% +19.19
pslorenz 98.15 3/2/2009 Outperform 5Y $7.94 +68.71% +50.34% +18.37 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackRWBaird 85.02 9/1/2009 Outperform NS $13.67 -2.07% +5.15% -7.22
TrackOppenheimer 26.63 4/27/2009 Outperform NS $10.73 +15.55% +15.32% +0.23 8/17/2009 @ $12.40
TrackRBCCapMkts 81.74 3/19/2009 Underperform NS $7.02 +95.89% +28.42% -67.47 11/2/2009 @ $13.75
TrackUBS 86.41 9/17/2008 Outperform NS $24.48 -57.52% -23.96% -33.56 5/27/2009 @ $10.40
TrackStifel 94.70 3/3/2008 Outperform NS $22.93 +9.52% -0.41% +9.93 6/20/2008 @ $25.11
TrackWachovia 35.10 1/24/2008 Outperform NS $20.19 -33.69% -16.98% -16.71
TrackKeyBanc 90.40 12/19/2007 Outperform NS $20.25 -33.88% -23.51% -10.36
TrackAGEdwards 89.12 4/24/2007 Outperform NS $24.19 -44.65% -23.60% -21.06
TrackFBRCapitalM 75.98 10/24/2006 Outperform NS $26.13 -46.00% -22.68% -23.32 9/21/2009 @ $14.11
TrackRWBaird 85.02 8/30/2006 Outperform NS $29.74 -31.20% +2.52% -33.72 2/22/2008 @ $20.46
TrackRBCCapMkts 81.74 8/21/2006 Outperform NS $28.36 -24.89% +1.58% -26.47 3/6/2008 @ $21.30
TrackJimCramer < 20 3/16/2006 Underperform 3W $24.41 -45.15% -12.24% +32.90

Featured Broker Partners